Suppr超能文献

影响骨质量的疾病:超越骨质疏松症。

Diseases affecting bone quality: beyond osteoporosis.

机构信息

Department of Orthopaedic Surgery, Hospital for Special Surgery, and Weill Cornell Medical College, Cornell University, 535 East 70th Street, New York, NY 10021, USA.

出版信息

Clin Orthop Relat Res. 2011 Aug;469(8):2194-206. doi: 10.1007/s11999-010-1694-9.

Abstract

BACKGROUND

Bone quantity, quality, and turnover contribute to whole bone strength. Although bone mineral density, or bone quantity, is associated with increased fracture risk, less is known about bone quality. Various conditions, including disorders of mineral homeostasis, disorders in bone remodeling, collagen disorders, and drugs, affect bone quality.

QUESTIONS/PURPOSES: The objectives of this review are to (1) identify the conditions and diseases that could adversely affect bone quality besides osteoporosis, and (2) evaluate how these conditions influence bone quality.

METHODS

We searched PubMed using the keywords "causes" combined with "secondary osteoporosis" or "fragility fracture." After identifying 20 disorders/conditions, we subsequently searched each condition to evaluate its effect on bone quality.

RESULTS

Many disorders or conditions have an effect on bone metabolism, leading to fragility fractures. These disorders include abnormalities that disrupt mineral homeostasis, lead to an alteration of the mineralization process, and ultimately reduce bone strength. The balance between bone formation and resorption is also essential to prevent microdamage accumulation and maintain proper material and structural integrity of the bone. As a result, diseases that alter the bone turnover process lead to a reduction of bone strength. Because Type I collagen is the most abundant protein found in bone, defects in Type I collagen can result in alterations of material property, ultimately leading to fragility fractures. Additionally, some medications can adversely affect bone.

CONCLUSIONS

Recognizing these conditions and diseases and understanding their etiology and pathogenesis is crucial for patient care and maintaining overall bone health.

摘要

背景

骨量、质量和转换率共同构成了整体骨强度。尽管骨矿物质密度(即骨量)与骨折风险增加有关,但对骨质量的了解较少。各种情况,包括矿物质内稳态紊乱、骨重塑紊乱、胶原紊乱和药物等,都会影响骨质量。

问题/目的:本综述的目的是(1)确定除骨质疏松症以外可能对骨质量产生不利影响的条件和疾病,(2)评估这些情况如何影响骨质量。

方法

我们使用关键词“原因”结合“继发性骨质疏松症”或“脆性骨折”在 PubMed 上进行搜索。在确定了 20 种疾病/状况后,我们随后对每种情况进行搜索,以评估其对骨质量的影响。

结果

许多疾病或状况会影响骨代谢,导致脆性骨折。这些疾病包括破坏矿物质内稳态、导致矿化过程改变、最终降低骨强度的异常情况。骨形成和吸收之间的平衡对于防止微损伤积累和维持骨的适当材料和结构完整性也很重要。因此,改变骨转换过程的疾病会导致骨强度降低。由于 I 型胶原是骨骼中含量最丰富的蛋白质,因此 I 型胶原的缺陷会导致材料特性的改变,最终导致脆性骨折。此外,一些药物也会对骨骼产生不良影响。

结论

认识到这些情况和疾病,并了解它们的病因和发病机制,对于患者护理和维持整体骨骼健康至关重要。

相似文献

1
Diseases affecting bone quality: beyond osteoporosis.
Clin Orthop Relat Res. 2011 Aug;469(8):2194-206. doi: 10.1007/s11999-010-1694-9.
2
Factors affecting bone strength other than osteoporosis.
Aging Clin Exp Res. 2013 Oct;25 Suppl 1:S9-11. doi: 10.1007/s40520-013-0098-6. Epub 2013 Sep 18.
5
Bone quality and osteoporosis therapy.
Arq Bras Endocrinol Metabol. 2010 Mar;54(2):186-99. doi: 10.1590/s0004-27302010000200015.
6
Important determinants of bone strength: beyond bone mineral density.
J Clin Rheumatol. 2006 Apr;12(2):70-7. doi: 10.1097/01.rhu.0000208612.33819.8c.
8
Biomechanics of bone: determinants of skeletal fragility and bone quality.
Osteoporos Int. 2002;13(2):97-104. doi: 10.1007/s001980200000.

引用本文的文献

2
Rhythms in Remodeling: Posttranslational Regulation of Bone by the Circadian Clock.
Biomedicines. 2025 Mar 13;13(3):705. doi: 10.3390/biomedicines13030705.
3
Microbial Extracellular Vesicles in Host-Microbiota Interactions.
Results Probl Cell Differ. 2024;73:475-520. doi: 10.1007/978-3-031-62036-2_19.
4
Inhibition of cysteine protease disturbs the topological relationship between bone resorption and formation in vitro.
J Bone Miner Metab. 2024 Mar;42(2):166-184. doi: 10.1007/s00774-023-01489-w. Epub 2024 Feb 20.
5
Editorial: Genetic and molecular determinants in bone health and diseases.
Front Endocrinol (Lausanne). 2024 Jan 17;15:1347765. doi: 10.3389/fendo.2024.1347765. eCollection 2024.
6
Differential effects of teriparatide, denosumab and zoledronate on hip structural and mechanical parameters in osteoporosis; a real-life study.
J Endocrinol Invest. 2024 Jul;47(7):1667-1677. doi: 10.1007/s40618-023-02280-4. Epub 2024 Jan 9.
8
E-cigarette aerosol exposure effect on bone biomechanical properties in murine models.
J Biomech. 2024 Jan;162:111879. doi: 10.1016/j.jbiomech.2023.111879. Epub 2023 Nov 23.
9
Leptin receptor gene deficiency minimally affects osseointegration in rats.
Sci Rep. 2023 Sep 20;13(1):15631. doi: 10.1038/s41598-023-42379-5.
10
Near-infrared spectroscopy for structural bone assessment.
Bone Jt Open. 2023 Apr 7;4(4):250-261. doi: 10.1302/2633-1462.44.BJO-2023-0014.R1.

本文引用的文献

3
Implantation increases tensile strength and collagen content of self-assembled tendon constructs.
J Appl Physiol (1985). 2010 Apr;108(4):875-81. doi: 10.1152/japplphysiol.00921.2009. Epub 2010 Jan 28.
4
Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding.
N Engl J Med. 2010 Feb 11;362(6):521-8. doi: 10.1056/NEJMoa0907705. Epub 2010 Jan 20.
6
Hyperparathyroidism.
Lancet. 2009 Jul 11;374(9684):145-58. doi: 10.1016/S0140-6736(09)60507-9.
7
Osteogenesis imperfecta: recent findings shed new light on this once well-understood condition.
Genet Med. 2009 Jun;11(6):375-85. doi: 10.1097/GIM.0b013e3181a1ff7b.
9
Cancer treatment-related bone disease.
Crit Rev Eukaryot Gene Expr. 2009;19(1):47-60. doi: 10.1615/critreveukargeneexpr.v19.i1.20.
10
Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.
Osteoporos Int. 2009 Aug;20(8):1353-62. doi: 10.1007/s00198-008-0805-x. Epub 2008 Dec 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验